Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects

Annals of General Psychiatry

Volumn 9, Issue , 2010, Pages

  Fukami, Goro ^a   Hashimoto, Tasuku ^a   Shirayama, Yukihiko ^a   Hasegawa, Tadashi ^a   Watanabe, Hiroyuki ^a   Fujisaki, Mihisa ^a   Hashimoto, Kenji ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYL LOFLAZEPATE; ETIZOLAM;

ADOLESCENT; ADULT; ARTICLE; COGNITION; DRUG ELIMINATION; EVENT RELATED POTENTIAL; FEMALE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PSYCHOLOGIC TEST;

EID: 78049346110     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-9-37     Document Type: Article

References (32)

1. Files SE, Lister RG. Lorazepam-induced deficits in learning result from impaired rehearsal, reduced motivation, or increased sedation?. Br J Clin Pharmacol 1982, 14:545-550. 1427596, 6128017.
2. Block RI, Berchou R. Alprazolam and lorazepam effects on memory acquisition and retrieval processes. Pharmac Biochem Behav 1984, 20:233-241.
3. Curran HV. Tranquilizing memories: a review of the effects of benzodiazepines on human memory. Biol Psychology 1986, 23:179-213.
4. Chouinard GJ. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004, 65(Suppl 5):7-12.
5. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005, 66(Suppl 2):9-13.
6. Urata J, Uchiyama M, Iyo M, Enomoto T, Hayakawa T, Tomiyama M, Nkajima T, Sasaki H, Shirakawa S, Wada K, Fukui S, Yamadera H, Okawa M. Effects of a small dose of triazolam on P300 and resting EEG. Psychopharmacology 1996, 125:179-184. 10.1007/BF02249418, 8783393.
7. Polich J, Kok A. Cognitive and biological determinants of P300: an integrative review. Biol Psychology 1995, 41:103-146.
8. Emmerson RY, Dustman RE, Shearer DE, Turner CW. P3 latency and symbol digit performance correlations in aging. Exp Aging Res 1989, 15:151-159.
9. O'Donell BF, Friedman S, Swearer JM, Drachman DA. Active and passive P3 latency and psychometric performance: influence of age and individual differences. Int J Psychophysiol 1992, 12:187-195. 10.1016/0167-8760(92)90010-9, 1592672.
10. Knight RT, Scabini D. Anatomic bases of event-related potentials and their relationship to novelty detection in humans. J Clin Neurophysiol 1998, 15:3-13. 10.1097/00004691-199801000-00003, 9502509.
11. Fjell AM, Walhovd KB. P300 and neuropsychological tests as measures of aging: salp topography and cognitive changes. Brain Topogr 2001, 14:25-40. 10.1023/A:1012563605837, 11599530.
12. McAllister-Williams RH, Massey AE, Rugg MD. Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval. Psychopharmacology 2002, 160:434-442. 10.1007/s00213-001-0996-8, 11919671.
13. Walhoved KB, Fjell AM. The relationship between P3 and neuropsychological function in an adult life span sample. Biol Psychology 2003, 62:65-87.
14. Pogarell O, Mulert C, Hegerl U. Event related potentials and fMRI in neuropsychopharmacology. Clin EEG Neurosci 2006, 37:99-107.
15. Berchou R, Chiyasirisobhon S, Green V, Mason K. The pharmacodynamic properties of lorazepam and methylphenidate drugs on event-related potentials and power spectral analysis in normal subjects. Clin Electroencephalogr 1986, 17:176-180.
16. Shinotoh H, Iyo M, Yamada T, Inoue O, Suzuki K, Itoh T, Fukuda H, Yamasaki T, Tateno Y, Hirayama K. Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography. Psychopharmacology 1989, 99:202-207. 10.1007/BF00442808, 2552484.
17. Rockstroh B, Elbert T, Lutzenberger W, Altenmuller E. Effects of the anticonvulsant benzodiazepine clonazepam on event-related brain potentials in humans. Electroencephalogr Clin Neurophysiol 1991, 78:142-149. 10.1016/0013-4694(91)90114-J, 1704837.
18. Semlitsch HV, Anderer P, Saletu B. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects. Eur J Clin Pharmacol 1995, 49:183-191. 10.1007/BF00192378, 8665994.
19. Nichols JM, Martin F. The effect of lorazepam on memory and event-related potentials in heavy and light social drinkers. Psychophysiology 1996, 33:446-456. 10.1111/j.1469-8986.1996.tb01070.x, 8753945.
20. Hayakawa T, Uchikawa M, Urata J, Enomoto T, Okubo J, Okawa M. Effects of small dose of triazolam on P300. Psychiatry Clin Neurosci 1999, 53:185-187. 10.1046/j.1440-1819.1999.00530.x, 10459684.
21. Chambon JP, Perio A, Demarne H, Hallot A, Dantzer R, Roncucci R, Biziere K. Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities. Arzneimittelforschung 1985, 35:1573-1577.
22. Tsumagari T, Nakajima A, Fukuda T, Shuto S, Kenjo T, Morimoto Y, Takigawa Y. Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepine (Y-7131), a new anti-anxiety drug. Arzneimittelforschung 1978, 28:1158-64.
23. Inagaki A, Inada T, Fujii Y, Yagi K, Yoshio T, Nakamura H, Yamauchi T. Dose equivalence of psychotropic drugs [in Japanese] 1999, 99-121. Tokyo, Japan: Seiwa Shoten Co. Ltd.
24. Inada T, Nozaki S, Inagaki A, Furukawa TA. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan. Human Psychopharmac Clin Exp 2003, 18:483-487.
25. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery 1985, Tucson, AZ, USA: Neuropsychology Press.
26. Smith A. Symbol Digit Modalities Test (SDMT): Manual (revised) 1982, Los Angeles, CA, USA: Western Psychological Services.
27. Wechsler DA. Wechsler Memory Scale-Revised, Manual 1987, New York, USA: Psychological Corp.
28. Kutas M, McCarthy G, Donchin E. Augmenting mental chronometry: the P300 as a measure of stimulus evaluation time. Science 1977, 197:792-795. 10.1126/science.887923, 887923.
29. McCarthy G, Donchin E. A metric for thought: a comparison of P300 latency and reaction time. Science 1981, 211:77-80. 10.1126/science.7444452, 7444452.
30. Magliero A, Bashoe TR, Coles MG, Donchin E. On the dependence of P300 latency on stimulus evaluation processes. Psychophysiology 1984, 21:171-186. 10.1111/j.1469-8986.1984.tb00201.x, 6728983.
31. Higashima M, Nagasawa T, Kawasaki Y, Oka T, Sakai N, Tsukada T, Koshino Y. Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies. Schizophr Res 2001, 59:147-157.
32. Iwanami A, Okajima Y, Isono H, Shinoda J, Kasai K, Hata A, Fukuda M, Nakagome K, Kamijima K. Effects of risperidone on event-related potential in schizophrenic patients. Pharmacopsychiatry 2001, 34:73-79. 10.1055/s-2001-15181, 11302567.